Treatment options in the management of necrotising fasciitis caused by Group A Streptococcus

Bibliography

• CENTERS FOR DISEASE CONTROL: Summary of notifiable diseases - United States, 2000. MMWR Morb. Mortal. Wkly Rep. (2002) 49(53):i-xxii, 1–100.
   Google Scholar
• HOGE CW, SCHWARTZ B, TALKINGTON DF, BREIMAN RF, MACNEILL EM, ENGLENDER SJ: The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA (1993) 269(3):384–389.
   Google Scholar
• KAUL R, MCGEER A, LOW DE et al.: Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Am. J. Med. (1997) 103:18–24.
   PubMed Web of Science ®Google Scholar
• ••A well-conducted study that examined theeffect of clindarnycin and IVIg on mortality.
   Google Scholar
• BISNO AL, STEVENS DL: Streptococcus pyogenes. In: Mandell, Douglas and Bennett's principles and practice of infectious diseases (5th edn). Mandell GL, Bennett JE, Dolin R, (Eds), Churchill Livingstone, Inc., New York, NY, USA (2000):2101–2102.
   Google Scholar
• TSAI P, LIN Y, KUO C et al: Group A Streptococcus induces apoptosis in human epithelial cells. Infect. Litman. (1999) 67:4334–4339.
   Web of Science ®Google Scholar
• COMMITTEE ON INFECTIOUS DISEASES, AMERICAN ACADEMY OF PEDIATRICS: Group A streptococcal infections. In: Red book (25thedn). American Academy of Pediatrics, Elk Grove Village, IL, USA (2000):526–536.
   Google Scholar
• KISKA DL, THIEDE B, CARACCIOLO J et al.: Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J. Infect. Dis. (1997) 176:992–1000.
   PubMed Web of Science ®Google Scholar
• KOTB M: Bacterial pyrogenic exotwdns assuperantigens. Clin. Microbiol Rev (1995) 8:411–426.
   PubMed Web of Science ®Google Scholar
• SKOV L, BAADSGAARD O: Bacterial superantigens and inflammatory skin diseases. Clin. Exp. Dermatol (2000) 25:57–61.
   PubMed Web of Science ®Google Scholar
• SCHLIEVERT PM, ASSIMACOPOULOS AP, CLEARY PP: Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. J. Lab. Clin. Med. (1996) 127:13–22.
   PubMed Web of Science ®Google Scholar
• NADAL D, LAUENER RP, BRAEGGER CP et al: T cell activation and cytokine release in streptococcal toxic shock-like syndrome. J. Pediam (1993) 122:727–729.
   Web of Science ®Google Scholar
• STEVENS DL, BRYANT AE, HACKETT SP et al: Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure. J. Infect. Dis. (1996) 173:619–626.
   PubMed Web of Science ®Google Scholar
• •Using a baboon model of GAS bacteraemia, this study showed that the cytoldne, TNF-a, plays an important role in the induction of shock and organ failure.
   Google Scholar
• BASMA H, NORRBY-TEGLUND A, GUEDEZ Y et al.: Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect. Litman. (1999) 67:1871–1877.
   Web of Science ®Google Scholar
• STEVENS DL: Invasive group A Streptococcus infections. Clin. Infect. Dis. (1992) 14:2–11.
   PubMed Web of Science ®Google Scholar
• MELENEY FL: Hemolytic streptococcus gangrene. Arch. Surg. (1924) 9:317–364.
   Google Scholar
• •A classic paper in the streptococcal NF literature.
   Google Scholar
• MULLA ZD: Invasive group A streptococcal disease and intensive care unit admissions. Intensive Care Med. (2002) 28:1822–1824.
   PubMed Web of Science ®Google Scholar
• WARD RG, WALSH MS: Necrotizing fasciitis: 10 years' experience in a district general hospital. Br.j Surg. (1991) 78:488–489.
   PubMed Web of Science ®Google Scholar
• STEVENS DL: Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg. Infect. Dis. (1995) 1:69–78.
   PubMed Web of Science ®Google Scholar
• •A good synopsis of the identification and treatment of this life-threatening infection.
   Google Scholar
• THE WORKING GROUP ON SEVERE STREPTOCOCCAL INFECTIONS: Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA (1993) 269:390–391.
   PubMed Web of Science ®Google Scholar
• BERNALDO DE QUIROS JCL, MORENO S, CERCENADO E et al: Group A streptococcal bacteremia: a 10-year prospective study. Medicine (Baltimore) (1997) 76:238–248.
   PubMed Web of Science ®Google Scholar
• FRANCIS J, WARREN RE: Streptococcus pyogenes bacteraemia in Cambridge - a review of 67 episodes. Q. J. Med. (1988) 68:603–613.
   PubMedGoogle Scholar
• KRISTENSEN B, SCHONHEYDER HC: A 13-year survey of bacteraemia due to 13-haemolytic streptococci in a Danish county. J. Med. Microbiol (1995) 43:63–67.
   PubMed Web of Science ®Google Scholar
• CENTERS FOR DISEASE CONTROL AND PREVENTION: Summary of notifiable diseases, United States, 1995. MMWR Morb. Mortal. Wkly Rep. (1996) 44:iii-iv.
   Google Scholar
• O'BRIEN KL, BEALL B, BARRETT NL et al.: Epidemiology of invasive group A Streptococcus disease in the United States, 1995–1999. Gin. Infect. Dis. (2002) 35:268–276.
   Google Scholar
• •A comprehensive report on the descriptive epidemiology of this condition in the US. Rate ratios for mortality are also reported.
   Google Scholar
• DAVIES HD, MCGEER A, SCHWARTZ B et al.: Invasive group A streptococcal infections in Ontario, Canada. N Engl. J. Med. (1996) 335:547–554.
   PubMed Web of Science ®Google Scholar
• ••An excellent prospective study that waspopulation-based. The issue of chemoprophylaxis of close contacts is addressed.
   Google Scholar
• ERIKSSON BKG, ANDERSSON J, HOLM SE et al.: Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clin. Infect. Dis. (1998) 27:1428–1436.
   PubMed Web of Science ®Google Scholar
• FACTOR SH, LEVINE OS, SCHWARTZ B et al.: Invasive group A streptococcal disease: risk factors for adults. Emeig. Infect. Dis. (2003) 9:970–977.
   PubMed Web of Science ®Google Scholar
• •A case-control study that identified cases from three areas: metropolitan Atlanta, GA, USA; metropolitan Baltimore, MD, USA; and the Toronto-Peel region of Ontario, Canada.
   Google Scholar
• CENTERS FOR DISEASE CONTROL AND PREVENTION: Outbreak of invasive group A Streptococcus associated with varicella in a childcare center - Boston, Massachusetts, 1997. MMWR Moth. Mortal. Wkly Rep. (1997) 46:944–948.
   PubMedGoogle Scholar
• LAUPLAND KB, DAVIES HD, LOW DE et al.: Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Pediatrics (2000) 105:E60.
   PubMed Web of Science ®Google Scholar
• ZURAWSKI CA, BARDSLEY M, BEALL B et al: Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clin. Infect. Dis. (1998) 27:150–157.
   PubMed Web of Science ®Google Scholar
• VEENSTRA RP, MANSON WE, VAN DER WERF TS et al: Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. Intensive Care Med. (2001) 27:1831.
   PubMed Web of Science ®Google Scholar
• BARNHAM MRD, WEIGHTMAN NC, ANDERSON AW, TANNA A: Streptococcal toxic shock syndrome: a description of 14 cases from North Yorkshire, UK. Clin. Microbial. Infect. (2002) 8:174–181.
   PubMed Web of Science ®Google Scholar
• STEVENS DL: Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin. Infect. Dis. (1995) 21:977–980.
   Web of Science ®Google Scholar
• SHARKAWY A, LOW DE, SAGINUR R et al.: Severe group A streptococcal soft-tissue infections in Ontario: 1992-1996. Clin. Infect. Dis. (2002) 34:454–460.
   PubMed Web of Science ®Google Scholar
• MULLA ZD: Nonsteroidal anti-inflammatory drugs and hypotension among patients hospitalized for invasive group A streptococcal disease. Ann. Epidemiol (2003) 13:543–544.
   PubMed Web of Science ®Google Scholar
• ARON OFF DM, BLOCH KC: Assessingthe relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A Streptococcus. Medkine (Baltimore) (2003) 82:225–235.
   PubMed Web of Science ®Google Scholar
• EAGLE H: Experimental approach to theproblem of treatment failure with penicillin. I. Group A streptococcal infections in mice. Am. J. Med. (1952) 13:389–399.
   Google Scholar
• •A classic study on the pharmacotherapy of GAS infections.
   Google Scholar
• STEVENS DL, GIBBONS AE, BERGSTROM R et al.: The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. Infect. Dis. (1988) 158:23–28.
   Web of Science ®Google Scholar
• ••This important study illustrated thatdindarnycin is superior to penicillin in a mtnine model of streptococcal myositis when the treatment was delayed.
   Google Scholar
• MEDICAL ECONOMICS COMPANY, INC: Physician's de.ck reference (55th edit), Medical economics company, Inc., Montvale, NJ, USA (2001).
   Google Scholar
• ZIMBELMAN J, PALMER A, TODD J: Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr. Infect. Dis. (1999) 18:1096–1100.
   Google Scholar
• ••This is the first published epidemiologicalstudy to conclude that dindarnycin in combination with a B-lactarn antibiotic might be the most effective treatment for invasive GAS infection.
   Google Scholar
• MULLA ZD, LEAVERTON PE, WIERSMA ST: Invasive group A streptococcal infections in Florida. South. Med. J. (2003) 96:968–973.
   PubMed Web of Science ®Google Scholar
• •This is the second epidemiological study to find a statistically significant association between treatment with clindarnycin and a favourable outcome, which in this study, was reduced mortality. The protective effect of dindarnycin was only noted among patients with NF and not in the larger group who had other manifestations of invasive GAS disease.
   Google Scholar
• PATEL R, ROUSE MS, FLOREZ MV et al.: Lack of benefit of intravenous immune globulin in a murine model of group A streptococcal necrotizing fasciitis. J. Infect. Dis. (2000) 181:230–234.
   PubMed Web of Science ®Google Scholar
• NORRBY-TEGLUND A, IHENDYANE N, DARENBERG J: Intravenous immunoglobulin adjunctive therapy in sepsis, with special emphasis on severe invasive group A streptococcal infections. Scand J. Infect. Dis. (2003) 35:683–689.
   PubMed Web of Science ®Google Scholar
• ••This paper summarises studies thatexamined IVIg as a treatment for sepsis and as an adjunctive therapy for severe invasive GAS infections.
   Google Scholar
• KAUL R, MCGEER A, NORRBY-TEGLUND A et al.: Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome - a comparative observational study. Clin. Infect. Dis. (1999) 28:800–807.
   PubMed Web of Science ®Google Scholar
• MCHENRY CR, PIOTROWSKI JJ, PETRINIC D et al.: Determinants of mortality for necrotizing soft-tissue infections. Ann. Surg. (1995) 221:558–563.
   PubMed Web of Science ®Google Scholar
• OPAL SM: Interactions between coagulation and inflammation. Scand. Infect. Dis. (2003) 35:545–554.
   PubMed Web of Science ®Google Scholar
• PURNELL D, HAZLETT T, ALEXANDER SL: A new weapon against severe sepsis related to necrotizing fasciitis. Dimens. Crit. Care. Nurs. (2004) 23:18–23.
   PubMedGoogle Scholar
• BISNO AL, COCKERILL FR 3rd, BERMUDEZ CT: The initial outpatient-physician encounter in group A streptococcal necrotizing fasciitis. Clin. Infect. Dis. (2000) 2:607–608.
   Web of Science ®Google Scholar
• DALAL M, STERNE G, MURRAY DS: Streptococcal myositis: a lesson. Br. J. Plast. Surg. (2002) 55:682–684.
   PubMedGoogle Scholar
• MAJESKI JA, JOHN JF Jr: Necrotizing soft tissue infections: a guide to early diagnosis and initial therapy. South. Med. J. (2003) 96:900–905.
   PubMed Web of Science ®Google Scholar
• •This paper reviews the classification, diagnosis, and treatment of NE
   Google Scholar
• http://www.cdc.gov/ncidod/dbmd/diseaseinf o/groupastreptococcal_thtm CENTERS FOR DISEASE CONTROL AND PREVENTION: Group A streptococcal (GAS) disease: technical information. Accessed April 9 (2004).
   Google Scholar